Stem-cell firms surge as Obama fuels funding hopes
BANGALORE (Reuters) - Shares of companies developing therapies based on stem cells surged on Monday, after confirmation over the weekend that U.S. president-elect Barack Obama plans to reverse an existing executive order against federal funding of embryonic stem-cell research.</p><div class="feedflare">
<img src="http://feedproxy.google.com/~f/reuters/scienceNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=skylBxUb) <img src="http://feedproxy.google.com/~f/reuters/scienceNews?i=64VQHYRL" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=64VQHYRL) <img src="http://feedproxy.google.com/~f/reuters/scienceNews?i=3XnFmTfE" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=3XnFmTfE)
</div><img src="http://feedproxy.google.com/~r/reuters/scienceNews/~4/evCwj0s1aLo" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/scienceNews/~3/evCwj0s1aLo/idUSTRE4A96WW20081110